Rankings
▼
Calendar
NAGE FY 2022 Earnings — Niagen Bioscience Inc Revenue & Financial Results | Market Cap Arena
NAGE
Niagen Bioscience Inc
$423M
FY 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$72M
+6.8% YoY
Gross Profit
$43M
59.4% margin
Operating Income
-$19M
-25.9% margin
Net Income
-$17M
-23.0% margin
EPS (Diluted)
$-0.24
Cash Flow
Operating Cash Flow
-$15M
Free Cash Flow
-$15M
Stock-Based Comp.
$6M
Balance Sheet
Total Assets
$54M
Total Liabilities
$25M
Stockholders' Equity
$29M
Cash & Equivalents
$20M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$72M
$67M
+6.8%
Gross Profit
$43M
$41M
+3.2%
Operating Income
-$19M
-$27M
+31.2%
Net Income
-$17M
-$27M
+39.0%
← Q4 2021
All Quarters
Q1 2022 →